Prognostic Significance of p53 and Ki67 Proteins Expression in Greek Gastric Cancer Patients

References

• Siewert J. R., Sendler A. The current management of gastric cancer. Adv Surg, 1999, 33: 69–93.
   Google Scholar
• Gill S., Shah A., Le N., Cook E. F., Yoshida E. M. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. J Clin Oncol, 2003, 21: 2070–2076.
   Google Scholar
• Mc Culloch P., Taggart T., Ochiai A., O’dowd G., Nash J., Sasako M. c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol, 1997, 23: 304–309.
   Google Scholar
• Schuhmacher C. P., Fink U., Becker K. et al. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etopo-side, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer, 2001, 91: 918–927.
   Google Scholar
• Dicken B. J., Saunders L. D., Jhangri G. S. et al. Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol, 2004, 11: 629–635.
   Google Scholar
• Zolota V., Batistatou A., Tsamandas A. C., Iliopoulos G., Scopa C. D., Bonikos D. S. Immunohistochemical expression of TGF-betal, p21WAF1, p53, Ki67, and angiogenesis in gastric carcinomas: a clinicopathologic study. Int J Gastrointest Cancer, 2002, 32: 83–89.
   Google Scholar
• Steele R. J., Thompson A. M., Hall P. A., Lane D. P. The p53 tumour suppressor gene. Br J Surg, 1998, 85: 1460–1467.
   Google Scholar
• Fenoglio-Preiser C. M., Wang J., Stemmermann G. N., Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat, 2003, 21: 258–270.
   Google Scholar
• Wong S. K., Seow-Choen F., Leong A. P., Ho Y. H., Aw S. E. Mutant plasma p53 protein levels: prognostication in colorectal carcinoma. Br J Surg, 1997, 84: 664–665.
   Google Scholar
• Hashimoto N., Tachibana M., Dhar D. K., Yoshimura H., Nagasue N. Expression of p53 and RB proteins in squamous cell carcinoma of the esophagus: their relationship with clinicopatho-logic characteristics. Ann Surg Oncol, 1999, 6: 489–494.
   Google Scholar
• Reed W., Hannisdal E., Boehler P. J., Gundersen S., Host H., Marthin J. The prognostic value of p53 and c-erb B-2 immuno-staining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14–30 years. Cancer, 2000, 88: 804–813.
   Google Scholar
• Maehara Y., Tomoda M., Hasuda S. et al. Prognostic value of p53 protein expression for patients with gastric cancer-a multivariate analysis. Br J Cancer, 1999, 79: 1255–1261.
   Google Scholar
• Maehara Y., Kakeji Y., Watanabe A. et al. Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma. Cancer, 1999, 85: 302–308.
   Google Scholar
• Roviello F., Marrelli D., Vindigni C., De Stefano A., Spina D., Pinto E. P53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type. Ann Surg Oncol, 1999, 6: 739–745.
   Google Scholar
• Lee K. E., Lee H. J., Kim Y. H. et al. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol, 2003, 33: 173–179.
   Google Scholar
• Lim B. H., Soong R., Grieu F., Robbins P. D., House A. K., Iacopetta B. J. p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma. Int J Cancer, 1996, 69: 200–204.
   Google Scholar
• Brown D. C., Gatter K. C. Monoclonal antibody Ki-67: its use in histopathology. Histopathology, 1990, 17: 489–503.
   Google Scholar
• Victorzon M., Roberts P. J., Haglund C., Von Boguslawsky K., Nordling S. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology, 1996, 53: 182–191.
   Google Scholar
• Victorzon M., Roberts P. J., Haglund C., Von Boguslawsky K., Nordling S. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer. Anticancer Res, 1997, 17: 2923–2926.
   Google Scholar
• Oshima C. T., Iriya K., Forones N. M. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer. Neoplasma, 2005, 52: 420–424.
   Google Scholar
• Yonemura Y., Ooyama S., Sugiyama K. et al. Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67. Cancer, 1990, 65: 1130–1134.
   Google Scholar
• Lauren P. The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. an Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand, 1965, 64: 31–49.
   Google Scholar
• Ming S. C. Gastric carcinoma. A pathobiological classification. Cancer, 1977, 39: 2475–2485.
   Google Scholar
• Takagane A., Terashima M., Abe K. et al. Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer. Gastric Cancer, 1999, 2: 122–128.
   Google Scholar
• CANCER AJCO. Stomach. In: Greene F. (ed.). AJCC Cancer Staging Manual. 5 edn. Philadelphia: Lippincot-Raven, 1997: 7176.
   Google Scholar
• Diez M., Medrano M. J., Gutierrez A. et al. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy. Anticancer Res, 2000, 20: 3929–3933.
   Google Scholar
• Kim J. H., Uhm H. D., Gong S. J. et al. Relationship between p53 overexpression and gastric cancer progression. Oncology, 1997, 54: 166–170.
   Google Scholar
• Al-Moundhri M. S., Nirmala V., Al-Hadabi I. et al. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol, 2005, 91: 243–252.
   Google Scholar
• Wang Z., Ikeguchi M., Maeta M., Kaibara N. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa. Anticancer Res, 1997, 17: 3701–3705.
   Google Scholar
• GomyoY., IkedaM., Osaki M. et al. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma. Cancer, 1997, 79: 2067–2072.
   Google Scholar
• Kaye P. V., Radebold K., Isaacs S., Dent D. M. Expression of p53 and p21waf1/cip1 in gastric carcinoma: lack of inter-relationship or correlation with prognosis. Eur J Surg Oncol, 2000, 26: 39–43.
   Google Scholar
• Muller W., Borchard F. Prognostic influence of p53 expression in gastric cancer. J Pathol, 1996, 178: 255–258.
   Google Scholar
• Sanz-Ortega J., Steinberg S. M., Moro E. et al. Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol Histopathol, 2000, 15: 455–462.
   Google Scholar
• Pinto-De-Sousa J., David L., Seixas M., Pimenta A. Clinico-pathologic profiles and prognosis of gastric carcinomas from the cardia, fundus/body and antrum. Dig Surg, 2001, 18: 102–110.
   Google Scholar
• Tang H., Hokita S., Che X. et al. Comparison of p53 expression in proximal and distal gastric cancer: histopathologic correlation and prognostic significance. Ann Surg Oncol, 1997, 4: 470–474.
   Google Scholar
• Ozguroglu M., Demir G. Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma. Cancer, 1999, 86: 547–549.
   Google Scholar
• Gilliland R., Williamson K. E., Wilson R. H., Anderson N. H., Hamilton P. W. Colorectal cell kinetics. Br J Surg, 1996, 83: 739–749.
   Google Scholar
• Kim J. Y., Cho H. J. DNA ploidy patterns in gastric adenocarcinoma. J Korean Med Sci, 2000, 15: 159–166.
   Google Scholar
• Maeda K, Chung Y. S, Takatsuka S. et al. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer, 1995, 72: 319–323.
   Google Scholar
• Mori M., Kakeji Y., Adachi Y. et al. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery, 1993, 113: 683–690.
   Google Scholar